目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T79550 | |||
Antifungalagent 68(compound 10)是抗真菌剂,针对念珠菌和格特隐球菌。它通过抑制麦角甾醇的生物合成发挥作用,靶向羊毛甾醇 14α-去甲基酶(CYP51)。Antifungalagent 68的咪唑环能与CYP51的血红素基团发生相互作用。 | |||
T78899 | |||
Laccase-IN-1 (compound 4b) 是一种口服laccase抑制剂,其IC50为11.3 μM。该化合物能够对苹果中的B. dothidea起到保护及治疗效果。它通过增强B. dothidea细胞膜的通透性、破坏其菌丝的表面形态以及细胞的超微结构,并且减少麦角甾醇和胞外多糖的含量,来发挥作用。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPH-03447 | ERG11 Protein, S. cerevisiae, Recombinant (GST) | Saccharomyces cerevisiae | E. coli | ||
Catalyzes C14-demethylation of lanosterol which is critical for ergosterol biosynthesis. It transforms lanosterol into 4,4'-dimethyl cholesta-8,14,24-triene-3-beta-ol.
|
|||||
TMPH-03460 | ERG26 Protein, S. cerevisiae, Recombinant (His & Myc) | SVG-Saccharomyces cerevisiae | E. coli | ||
Essential enzyme in the ergosterol biosynthetic pathway. Part of a 3 enzyme system that catalyzes the sequential removal of the 2 methyl groups at the sterol C-4 position, converting 4,4-dimethylzymosterol to zymosterol. Catalyzes the second step, an oxidative decarboxylation that results in a reduction of the 3-beta-hydroxy group at the C-3 carbon to an oxo group.
|
|||||
TMPH-03017 | CYP51 Protein, Mycobacterium tuberculosis, Recombinant (His & Myc) | Mycobacterium tuberculosis | Baculovirus | ||
Its precise biological substrate is not known. Catalyzes C14-demethylation of lanosterol, 24,25-dihydrolanosterol and obtusifoliol which is critical for ergosterol biosynthesis. It transforms lanosterol into 4,4'-dimethyl cholesta-8,14,24-triene-3-beta-ol.
|